Can medico-social and administrative organization improve the individual and collective management of tuberculosis in France?;L'organisation médico-sociale et administrative peut-elle améliorer la prise en charge individuelle et collective de la tuberculose en France?

Revue des Maladies Respiratoires

Volumn 21, Issue 3 II, 2004, Pages

  Chouaid, C ^a   Antoun, F ^b   Blanc Jouvan, F ^c   Cormier, K ^d   Portel, L ^e   Fraisse, P ^f  

^a HÔPITAL SAINT ANTOINE   (France)

^b Mairie Paris/Hop Prive Val d'Yerres   (France)

^c Isere Serv Prev Malad Resp   (France)

^d Tribunal d'Instance de Nanterre ^*  (France)

^e Service de Médecine Interne   (France)

^f HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; TUBERCULOSTATIC AGENT;

CONFERENCE PAPER; DIRECTLY OBSERVED THERAPY; FRANCE; HEALTH ECONOMICS; HUMAN; IMMIGRANT; SOCIAL STRUCTURE; THORAX RADIOGRAPHY; TUBERCULOSIS; TUBERCULOSIS CONTROL; HEALTH CARE DELIVERY; LUNG TUBERCULOSIS; ORGANIZATION AND MANAGEMENT; PUBLIC HEALTH; REVIEW; SOCIAL STATUS;

DELIVERY OF HEALTH CARE; FRANCE; HUMANS; PUBLIC HEALTH; SOCIAL CONDITIONS; TUBERCULOSIS, PULMONARY;

EID: 3242747424     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (46)

1. Cailhol J, Che D, Campese C, Decludt B: Les cas de tuberculose déclarés en France en 2001. BEH2003; 10: 54-8.
2. Antoun F, Momas I, Vieu V, Poinsard R, Crespy M: Suivi épidémiologique des cas de tuberculose dans les centres médico-sociaux de Paris pour l'année 1994. Rev Mal Resp 1998; 15: 171-6.
3. Enarson DA, Wang JS, Grzybowski S: Case-finding in the elimination phase of tuberculosis in displaced people. Bull Int Union Tuberc Lung Dis 1990; 65: 73-4.
4. Borgdorff MW, Floyd K, Broekmans JF: Interventions to reduce tuberculosis mortality and transmission in low and middle-income countries. Bull World Health Organ 2002; 80: 217-27.
5. Pitman R, Jarman B, Coker R: Tuberculosis transmission and the impact of intervention on the incidence of infection. Int J Tuberc Lung Dis 2002; 6: 485-91.
6. Behr MA, Hopewell PC, Paz EA, Kawamura LM, Schecter GF, Small PM: Predictive value of contact investigation for identifying recent transmission of Mycobacterium tuberculosis. Am J Respir Crit Care Med 1998; 158: 465-9.
7. Marks SM, Taylor Z, Qualls NL, Shrestha-Kuwahara RJ, Wilce MA, Nguyen CH: Outcomes of contact investigations of infectious tuberculosis patients. Am J Respir Crit Care Med 2000; 162: 2033-8.
8. Reichler MR, Reves R, Bur S, Thompson V, Mangura BT, Ford J, Valway SE, Onorato IM: Contact Investigation Study Group. Evaluation of investigations conducted to detect and prevent transmission of tuberculosis. JAMA 2002; 287: 991-5.
9. Noertjojo K, Tam CM, Chan SL, Tan J, Chan-Yeung M: Contact examination for tuberculosis in Hong Kong is useful. Int J Tuberc Lung Dis 2002; 6: 19-24.
10. Verver S, van Soolingen D, Borgdorff MW: Effect of screening of immigrants on tuberculosis transmission. Int J Tuberc Lung Dis 2002; 6: 121-9.
11. Capewell S, Leitch AG: The value of contact procedures for tuberculosis in Edinburgh. Br J Dis Chest 1984; 78: 317-29.
12. Verver S, Bwire R, Borgdorff MW: Screening for pulmonary tuberculosis among immigrants: estimated effect on severity of disease and duration of infectiousness. Int J Tuberc Lung Dis 2001; 5: 419-25.
13. Wang PD, Lin RS: Tuberculosis transmission in the family. J Infect 2000; 41: 249-51.
14. Centers of Disease Control and Prevention: Targeted tuberculin testing, and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000; 49: 1-51.
15. www.invs.sante.fr/surveillance/mdo/fiche/fiche-tuberculose.pdf
16. Chouaid C, Bourcier S, Delepierre F, Monnet I, Hosselet JJ, Atassi K, Housset B: Filières de soins des patients tuberculeux. Santé publique 1995; 3: 301-8.
17. Decludt B, Vaillant V, Hubert B: Evaluation de la qualité de la déclaration obligatoire de la tuberculose dans 16 départements français. BEH 1995; 12: 51-3.
18. Portel L, Salamon M, Pasquet S, Tessier JF, Daucourt V, Dabis F, Courty G: Notification et suivis des cas de tuberculose en gironde par un réseau de surveillance sur une période de 7 ans. Rev Mal Respir 1999; 16: 823-8.
19. Lo Bue PA, Moser KS: Use of isoniazid for latent tuberculosis infection in a public health clinic. Am J Respir Crit Care Med 2003; 168: 443-7.
20. Brewer TF, Heymann SJ, Kumplitsch SM, Wilson ME, Colditz GA, Fineberg HV: Strategies to decrease tuberculosis in US homeless population - a computer simulation model. JAMA 2001; 286: 834-42.
21. Brickner PW, Scanlan BC, Conanan B, Elvy A, McAdam J, Keen Scharer L, Vicic WJ: Homeless persons and health care. Ann Intern Med 1986; 104: 405-9.
22. Torres RA, Mani S, Altholz J, Brickner PW: Human immunodeficiency virus infection among homeless men in a New York City shelter. Association with Mycobacterium tuberculosis infection. Arch Intern Med 1990; 150: 2030-6.
23. Moss AR, Hahn JA, Tulsky JP, Daley CL, Small PM, Hopewell PC: Tuberculosis in the homeless. A prospective study. Am J Respir Crit Care Med 2000; 162: 460-4.
24. Falchook G, Gaffga C, Eve S, Ali J: Tuberculosis screening, referral, and treatment in an inner city homeless shelter in Orleans parish. J LA State Med Soc 2000; 152: 398-404.
25. Kimerling ME, Shakes CF, Carlisle R, Lok KH, Benjamin WH, Dunlap NE: Spot sputum screening: evaluation of an intervention in two homeless shelters. Int J Tuberc Lung Dis 1999; 3: 613-9.
26. Southern A, Premaratne N, English M, Balazs J, O'Sullivan D: Tuberculosis among homeless people in London: an effective model of screening and treatment. Int J Tuberc Lung Dis 1999; 3: 1001-8.
27. Jasmer RM, Nahid P, Hopewell PC: Clinical practice. Latent tuberculosis infection. N Engl J Med 2002; 347: 1860-6.
28. Grosset J, Zunic L, Morcrette C, Emmanuelli X: Directly Observed Treatment for homeless with tuberculosis in inner Paris. Int J Tuberc Lung Dis 2001; S272: 4.
29. Antoun F, Valin N, Chouaid C, Renard M, Dautzenberg B, Lalande V, Ayache B, Morin P, Sougakoff W, Thiolet JM, Truffot-Pernot C, Jarlier V, Dedudt B: Épidémie de tuberculose dans un foyer de migrants à Paris en 2002. BEH2003; 10: 58-61.
30. Ormerod P, Skinner C, Moore-Gillon J, Davies P, Connolly M, Gleissberg V, Watson J, Pozniak A: Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Joint tuberculosis committee of the BTS. Thorax 2000; 55: 887-901.
31. Hanau-Bercot B, Gremy I, Raskine L, Bizet J, Gutierrez MC, Boyer-Mariotte S, Bregeault A, Lagrange PH, Sanson Le Pors MJ: A one-year prospective study (1994-1995) for a first evaluation of tuberculosis transmission in French prisons. Int J Tuberc Lung Dis 2000; 4: 853-9.
32. Cummings KC, Mohle-Boetani J, Royce SE, Chin DP: Mouvement of tuberculosis patients and the failure to complete antituberculosis treatment. Am J Res Crit Care Med 1998; 157: 1249-52.
33. Lepetit C, Thebaud-Mony A: Tuberculose pulmonaire en Seine-Saint-Denis. Résultats du traitement. Rev Mal Respir 1989; 6: 451-6.
34. Walley JD, Khan MA, Newell JN, Khan MH: Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan. Lancet 2001; 357: 664-9.
35. Lwilla F, Schellenberg D, Masanja H, Acosta C, Galindo C, Aponte J, Egwaga S, Njako B, Ascaso C, Tanner M, Alonso P: Evaluation of efficacy of community-based vs. institutional-based direct observed short-course treatment for the control of tuberculosis in Kilombero district, Tanzania. Trop Med Int Health 2003; 8: 204-10.
36. Kamolratanakul P, Sawert H, Lertmaharit S, Kasetjaroen Y, Akksilp S, Tulaporn C, Punnachest K, Na-Songkhla S, Payanandana V: Randomized controlled trial of directly observed treatment (DOT) for patients with pulmonary tuberculosis in Thailand. Trans R Soc Trop Med Hyg 1999; 93: 552-7.
37. Volmink J, Garner P: Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 2003; 1: CD003343.
38. Hill AR, Manikal VM, Riska PF: Effectiveness of directly observed therapy (DOT) for tuberculosis: a review of multinational experience reported in 1990-2000. Medicine 2002; 81: 179-93.
39. Pilote L, Tulsky JP, Zolopa AR, Hahn JA, Schecter GF, Moss AR: Tuberculosis Prophylaxis in the Homeless. Arch Intern Med 1996; 156: 161-65.
40. Lobue PA, Cass R, Lobo D, Moser K, Catanzaro A: Development of housing programs to aid in the treatment of tuberculosis in homeless individuals: a pilot study. Preliminary Report. Chest 1999; 11: 218-23.
41. Diez E, Claveria J, Serra T, Cayla JA, Jansa JM, Pedro R, Villalbi JR: Evaluation of a social health intervention among homeless tuberculosis patients. Tuber Lung Dis 1996; 77: 420-4.
42. Singleton L, Turner M, Haskal R, Etkind S, Tricario M, Nardel E: Long-term hospitalization for tuberculosis control - experience with a medical-psychosocial inpatient unit. JAMA 1997; 278: 838-42.
43. Centers for Disease Control and Prevention: Tuberculosis control laws - United States, 1993: recommendations of the Advisory Council for the Elimination of Tuberculosis (ACET). MMWR 1993; 42: 1-28.
44. Gasner MR, Lay Maw K, Fieldman GE, Fujiwara PI, Frieden TR: The use of legal action in New York City to ensure treatment of tuberculosis. N Engl J Med 1999; 340: 359-66.
45. Oscherwitz T, Peterson Tulsky J, Roger S, Alpers A, Sciortino S, Royce S, Lo B: Detention of persistently nonadherent patients with tuberculosis. JAMA 1997; 278: 843-6.
46. Taylor Z: The cost-effectiveness of screening for latent tuberculosis infection. Int J Tuberc Lung Dis 2000; 4: S127-33.